Notice2024-00994
Bulk Manufacturer of Controlled Substances Application: Arista Biologicals
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 19, 2024
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Arista Biologicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 13 (Friday, January 19, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 13 (Friday, January 19, 2024)]
[Notices]
[Pages 3694-3695]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-00994]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1311]
Bulk Manufacturer of Controlled Substances Application: Arista
Biologicals
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Arista Biologicals has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
March 19, 2024. Such persons may also file a written request for a
hearing on the application on or before March 19, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 28, 2023, Arista Biologicals, 1101 Hamilton
Street, Allentown, Pennsylvania 18101-1043 applied to be registered as
a bulk manufacturer of the following basic class(es) of controlled
substance(s):
[[Page 3695]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
4-Anilino-N-Phenethyl-4-Piperidine 8333 II
(ANPP).
Norfentanyl (N-phenyl-N-(piperidin-4-yl) 8366 II
propionamide).
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the internal use as intermediates for formulation and
analytical development purposes. No other activities for these drug
codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-00994 Filed 1-18-24; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on January 19, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.